Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.
about
Place of mTOR inhibitors in management of BKV infection after kidney transplantationPolyomavirus-Specific Cellular Immunity: From BK-Virus-Specific Cellular Immunity to BK-Virus-Associated Nephropathy?Polyomaviruses and disease: is there more to know than viremia and viruria?The future direction and unmet needs of transplant immunosuppression.Lipid, blood pressure and kidney update 2013.Outcome in Pancreas Grafts After BK Virus Viremia in Simultaneous Pancreas-Kidney Transplants: A Single-Center Case Report.A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipientsSeroepidemiology of Human Polyomaviruses in a US Population.BK virus nephropathy in renal transplant recipients.BK viremia and polyomavirus nephropathy in 352 kidney transplants; risk factors and potential role of mTOR inhibition.Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodiesSequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation.BK Polyomavirus Replication in Renal Tubular Epithelial Cells Is Inhibited by Sirolimus, but Activated by Tacrolimus Through a Pathway Involving FKBP-12.Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses.BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches.Outcomes of renal transplant recipients with BK virus infection and BK virus surveillance in the Auckland region from 2006 to 2012.Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine.Transient versus persistent BK viremia and long-term outcomes after kidney and kidney-pancreas transplantation.Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation.Cellular immune therapy for viral infections in transplant patientsBK virus infection: an update on diagnosis and treatment.Opportunistic infections complicating solid organ transplantation with alemtuzumab induction.The safety of calcineurin inhibitors for kidney-transplant patients.The "ABC" of Virus-Specific T Cell Immunity in Solid Organ Transplantation.Imperfect Symmetry of Sp1 and Core Promoter Sequences Regulates Early and Late Virus Gene Expression of the Bidirectional BK Polyomavirus Noncoding Control Region.Infection rates in tacrolimus versus cyclosporine-treated pediatric kidney transplant recipients on a rapid discontinuation of prednisone protocol: 1-year analysis.Pre-transplant shedding of BK virus in urine is unrelated to post-transplant viruria and viremia in kidney transplant recipients.BK and JC polyomavirus infections in Tunisian renal transplant recipients.Incidence and outcome of BK polyomavirus infection in a multicenter randomized controlled trial with renal transplant patients receiving cyclosporine-, mycophenolate sodium-, or everolimus-based low-dose immunosuppressive therapy.Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.Molecular characterization of BK virus in patients infected with human immunodeficiency virus.BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies.The Frequency and Associated Factors for BK Virus Infection in a Center Performing Mainly Living Kidney Transplantations.Histological Evolution of BK Virus-Associated Nephropathy: Importance of Integrating Clinical and Pathological Findings.BK Polyomavirus-Specific 9mer CD8 T Cell Responses Correlate With Clearance of BK Viremia in Kidney Transplant Recipients: First Report From the Swiss Transplant Cohort Study.Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.Cryptococcal infections in solid organ transplant recipients over a 15-year period at a state transplant center.Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation.High-dose steroid therapy in BK viremia adversely affected the long-term graft function after kidney transplantation.
P2860
Q26751556-0FCB76FB-7971-41F0-829A-7774912CF50AQ26826085-5F93E1D4-8284-4552-8734-9ADD29A18EE1Q28081350-D2117564-5724-4365-8782-C3ECFAB28B8FQ30277037-F9512D82-5D20-4A62-9683-01853932C42BQ33574532-0FFD95F5-8BC7-4C02-B7AF-02AD3A376EBAQ33719816-F00FD9CF-C553-459C-AA1D-D4A09422C045Q33793057-828FE3BE-082C-4A45-BA3A-26BDEBB245A9Q34505098-D4EE2293-8833-4D38-8819-9A48E9771365Q34509585-15A264A9-29DD-4638-9372-4B489D660EA3Q35006676-FE1927DB-A05D-48E0-8E56-2104C5422CA5Q35228551-C37BBC87-5F14-4248-A83D-FDD7026909FEQ36297604-6B4FC13C-6A04-4CAB-B392-2686C1C905ACQ37215797-B9FDB637-CC38-4E3D-B829-A92054F50F60Q37340200-52B160BD-A4BE-448C-BBC6-FA0254A0F986Q37345783-FD2BDB1A-5448-40E4-8104-7F79B4D74D24Q37375153-2883AE79-9E73-4547-B9F3-95B72B78519CQ37399679-8318D90D-39B9-4279-BD7B-B13BA83D339FQ37522597-C9C88946-6B8C-4C38-949D-5470855A1A2AQ37621575-DFED5F78-1872-48DF-A341-0A05E4BA8D3CQ38154130-E56BE879-F4BC-4151-AB56-DB03D39B1F52Q38179174-71A4EEE6-6F5C-48D0-876D-CBF1EE0E2019Q38191554-077ACF56-149E-43F8-A68B-E3115C0C1B61Q38558078-0D02BC32-7D8A-4618-B908-95D9C8ED9ACCQ38578386-721346BF-1024-4468-B85B-3CDFA9C712F7Q38677902-44EE0AA9-DF7F-4654-8B24-1B17AA3F3231Q38736149-7CECC216-F7BA-46D2-A908-30D89A647C2FQ38858892-9A2A6E13-6B5F-410F-B9B3-9E93BB0EE498Q38908522-57CEF9A7-142D-499C-A73E-141CACE3A948Q38917217-8AA2FCFA-46F8-485D-B1EB-038E02409C2BQ38930188-3A2DEE73-631B-43A3-93F9-FE0FC64DB846Q38940498-6359C0C5-96C0-4155-BA6E-89819EF4DE66Q39120771-C747D5C6-27A0-46F5-95DE-FDCAF5855CDFQ39180715-4E4C1B33-DFBD-4BD9-BE5C-E73052E26261Q40159185-64708740-E760-4913-B495-602F44D12B56Q40236939-BA022359-F92C-4FE6-BBF5-05E3DD012654Q40281578-2EF3C6B2-8465-4A58-A2FA-11517D6E4F65Q40329754-AF04ECBD-9A91-430E-B873-FE69DBD1C551Q40440693-1160CE70-6064-4937-8692-3B8AF1A9CAAAQ40445539-BE69440E-48EB-4AD5-8272-6676564CD19FQ40500081-2BA37804-0E2A-465E-8FDF-4166FF7A56F8
P2860
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Polyomavirus BK replication in ...... randomized, multicenter study.
@ast
Polyomavirus BK replication in ...... randomized, multicenter study.
@en
type
label
Polyomavirus BK replication in ...... randomized, multicenter study.
@ast
Polyomavirus BK replication in ...... randomized, multicenter study.
@en
prefLabel
Polyomavirus BK replication in ...... randomized, multicenter study.
@ast
Polyomavirus BK replication in ...... randomized, multicenter study.
@en
P2093
P2860
P1476
Polyomavirus BK replication in ...... randomized, multicenter study.
@en
P2093
E H Scheuermann
F Citterio
F Vincenti
H H Hirsch
H Prestele
M D Pescovitz
P2860
P304
P356
10.1111/J.1600-6143.2012.04320.X
P407
P577
2012-11-08T00:00:00Z